Skip to main content

GeneGo Integrates Accelrys Software into ADME/Tox Product

NEW YORK, June 6 (GenomeWeb News) - GeneGo has integrated Accelrys' Accord chemistry engine with its MetaDrug ADME/Tox and medicinal chemistry platform, the St. Joseph, Mich.-based company said today.


MetaDrug contains pathways and networks for human proteins related to ADME/Tox. It allows researchers to predict metabolites and import microarray, proteomics, and metabolomics data.


Accelrys' Accord technology will now enable researchers to visualize molecules and search databases within MetaDrug.

The Scan

Pfizer-BioNTech Seek Full Vaccine Approval

According to the New York Times, Pfizer and BioNTech are seeking full US Food and Drug Administration approval for their SARS-CoV-2 vaccine.

Viral Integration Study Critiqued

Science writes that a paper reporting that SARS-CoV-2 can occasionally integrate into the host genome is drawing criticism.

Giraffe Species Debate

The Scientist reports that a new analysis aiming to end the discussion of how many giraffe species there are has only continued it.

Science Papers Examine Factors Shaping SARS-CoV-2 Spread, Give Insight Into Bacterial Evolution

In Science this week: genomic analysis points to role of human behavior in SARS-CoV-2 spread, and more.